{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-23-000020","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.597129+00:00","generated_at":"2026-06-15T15:15:46.669040+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ICU Medical Q1 revenue up 5% to $568.6M; GAAP loss narrows to $(0.41) from $(1.61)","bullets":["Revenue $568.6M vs $543.1M YoY; GAAP gross margin 34% vs 31%.","GAAP net loss $(9.8)M ($(0.41)/diluted share) vs $(38.1)M ($(1.61)) a year ago.","Adjusted diluted EPS $1.74 (down from $1.82); adjusted EBITDA $102.0M vs $84.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-23-000020","json":"https://secwatch.observer/filing/0000883984-23-000020.json","markdown":"https://secwatch.observer/filing/0000883984-23-000020.md","text":"https://secwatch.observer/filing/0000883984-23-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000020/0000883984-23-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000020/icui-20230508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T15:15:46.669040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"707698a1d4805f3fbcf6901c6c1368dab9be15b4","claim":"ICU MEDICAL INC/DE reported the quarter ended March 31, 2023 results: revenue $568.6 million, net income $(9.8) million, EPS $(0.41) per diluted share.","evidence_excerpt":"First quarter 2023 revenue was $568.6 million, compared to $543.1 million in the same period last year. GAAP gross profit for the first quarter of 2023 was $192.0 million, as compared to $168.8 million in the same period last year. GAAP gross margin for the first quarter of 2023 was 34%, as compared to 31% in the same period last year. GAAP net loss for the first quarter of 2023 was $(9.8) million, or $(0.41) per diluted share, as compared to GAAP net loss of $(38.1) million, or $(1.61) per diluted share, for the first quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000020/0000883984-23-000020-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$568.6 million"},{"label":"Net income","value":"$(9.8) million"},{"label":"EPS","value":"$(0.41) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}